Cargando…
N-acetycysteine: A potential therapeutic agent in COVID-19 infection
COVID-19 is an overwhelming pandemic which has shattered the whole world. Lung injury being the main clinical manifestation, it is likely to cause COPD (chronic obstructive pulmonary disease) and ARDS (acute respiratory distress syndrome). The possible cause behind this might be redox imbalance due...
Autores principales: | Jaiswal, N, Bhatnagar, M, Shah, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380211/ https://www.ncbi.nlm.nih.gov/pubmed/32758904 http://dx.doi.org/10.1016/j.mehy.2020.110133 |
Ejemplares similares
-
Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19
por: Shah, Jagat Narayan, et al.
Publicado: (2022) -
Withaferin A: a potential therapeutic agent against COVID-19 infection
por: Straughn, Alex R., et al.
Publicado: (2020) -
Neuroprotective Agents with Therapeutic Potential for COVID-19
por: Zaa, César A., et al.
Publicado: (2023) -
AYUSH- 64: A potential therapeutic agent in COVID-19
por: Panda, Ashok Kumar, et al.
Publicado: (2022) -
Potential Therapeutic Agents for Feline Calicivirus Infection
por: Fumian, Tulio M., et al.
Publicado: (2018)